ID26778A - SENYAWA ZAT BESI-DEKSTRAN UNTUK DIGUNAKAN SEBAGAI KOMPONEN PADA KOMPOSISI TERAPEUTIK UNTUK PENCEGAHAN ATAU PENGOBATAN KEKURANGAN ZAT BESI, ......... SECARA PARENTERAL (judul disingkat untuk bisa di update - Google Patents

SENYAWA ZAT BESI-DEKSTRAN UNTUK DIGUNAKAN SEBAGAI KOMPONEN PADA KOMPOSISI TERAPEUTIK UNTUK PENCEGAHAN ATAU PENGOBATAN KEKURANGAN ZAT BESI, ......... SECARA PARENTERAL (judul disingkat untuk bisa di update

Info

Publication number
ID26778A
ID26778A IDW20001881A ID20001881A ID26778A ID 26778 A ID26778 A ID 26778A ID W20001881 A IDW20001881 A ID W20001881A ID 20001881 A ID20001881 A ID 20001881A ID 26778 A ID26778 A ID 26778A
Authority
ID
Indonesia
Prior art keywords
iron
dextrane
parenteral
updating
prevention
Prior art date
Application number
IDW20001881A
Other languages
English (en)
Indonesian (id)
Inventor
Hans Berg Andreasen
Lars Christensen
Original Assignee
Pharmacosmos Holding As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8093321&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID26778(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacosmos Holding As filed Critical Pharmacosmos Holding As
Publication of ID26778A publication Critical patent/ID26778A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IDW20001881A 1998-03-25 1999-03-24 SENYAWA ZAT BESI-DEKSTRAN UNTUK DIGUNAKAN SEBAGAI KOMPONEN PADA KOMPOSISI TERAPEUTIK UNTUK PENCEGAHAN ATAU PENGOBATAN KEKURANGAN ZAT BESI, ......... SECARA PARENTERAL (judul disingkat untuk bisa di update ID26778A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK199800420A DK172860B1 (da) 1998-03-25 1998-03-25 Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman

Publications (1)

Publication Number Publication Date
ID26778A true ID26778A (id) 2001-02-08

Family

ID=8093321

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001881A ID26778A (id) 1998-03-25 1999-03-24 SENYAWA ZAT BESI-DEKSTRAN UNTUK DIGUNAKAN SEBAGAI KOMPONEN PADA KOMPOSISI TERAPEUTIK UNTUK PENCEGAHAN ATAU PENGOBATAN KEKURANGAN ZAT BESI, ......... SECARA PARENTERAL (judul disingkat untuk bisa di update

Country Status (28)

Country Link
US (1) US6291440B1 (fr)
EP (1) EP1066056B2 (fr)
JP (1) JP4558198B2 (fr)
KR (1) KR100612071B1 (fr)
CN (1) CN1147322C (fr)
AR (1) AR015738A1 (fr)
AT (1) ATE220560T1 (fr)
AU (1) AU740432B2 (fr)
BR (1) BRPI9908914B8 (fr)
CA (1) CA2322633C (fr)
CZ (1) CZ300823B6 (fr)
DE (1) DE69902154T3 (fr)
DK (2) DK172860B1 (fr)
EA (1) EA003427B1 (fr)
ES (1) ES2180279T5 (fr)
HK (1) HK1033426A1 (fr)
HU (1) HU228483B1 (fr)
ID (1) ID26778A (fr)
NO (1) NO329591B1 (fr)
NZ (1) NZ505983A (fr)
PL (1) PL195582B1 (fr)
PT (1) PT1066056E (fr)
SI (1) SI1066056T2 (fr)
SK (1) SK284499B6 (fr)
TR (1) TR200002733T2 (fr)
UA (1) UA70939C2 (fr)
WO (1) WO1999048533A1 (fr)
ZA (1) ZA200004016B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK173138B1 (da) * 1998-11-20 2000-02-07 Pharmacosmos Holding As Fremgangsmåde til fremstilling af en jerndextranforbindelse, jerndextranforbindelse fremstillet efter fremgangsmåden, farma
DK1169062T3 (da) * 1999-04-09 2010-01-25 Amag Pharmaceuticals Inc Varmestabile overtrukne kolloide jernoxider
US7871597B2 (en) 1999-04-09 2011-01-18 Amag Pharmaceuticals, Inc. Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents
KR20020003344A (ko) * 2001-12-17 2002-01-12 유형선 철분 보급제 경구 투여 제제 조성물
CN1309741C (zh) * 2002-04-09 2007-04-11 法玛科思莫斯控股有限公司 用于治疗缺铁性贫血的铁糊精化合物
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US20060116349A1 (en) * 2003-03-14 2006-06-01 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron for the treatment of restless leg syndrome
DE102004031181A1 (de) * 2004-06-28 2006-01-19 Vifor (International) Ag Phosphatadsorbens
ITMO20050056A1 (it) * 2005-03-15 2006-09-16 Biofer Spa Processo per la preparazione di complessi del ferro trivalente con zuccheri mono-, di- e polisaccaridi.
EP1757299A1 (fr) 2005-08-25 2007-02-28 Vifor (International) Ag Complexes de fer III pour traiter les manques de fer en patients avec la maladie intestinale inflammatoire
CN101365458B (zh) 2006-01-06 2012-09-05 卢特波尔德药品公司 用于铁给药的方法和组合物
EP1947120A1 (fr) * 2007-01-19 2008-07-23 Vifor (International) Ag Liaisons complexes d'hydrate de carbone de fer
EP1997833A1 (fr) * 2007-05-29 2008-12-03 Vifor (International) Ag Complexes fer-dérivé d'hydrate de carbone hydrosolubles, leur fabrication et médicaments contenants ces complexes
CN101585887B (zh) * 2008-05-22 2011-12-14 中国科学院过程工程研究所 应用纳滤技术对右旋糖酐铁络合物水溶液进行脱盐和浓缩的方法
NZ595597A (en) * 2009-03-25 2013-05-31 Pharmacosmos Holding As A stable iron oligosaccharide compound
CN101967205B (zh) * 2010-10-12 2013-04-17 滨州学院 一种β-葡聚糖铁复合物及其制备方法
EP2537866A1 (fr) * 2011-06-21 2012-12-26 Serumwerk Bernburg AG Dérivés d'amidon hydroxyéthyle, procédé de fabrication de ceux-ci et leurs utilisations thérapeutiques
PL398814A1 (pl) 2012-04-16 2013-10-28 Uniwersytet Jagiellonski Zastosowanie pochodnych dekstranu do przeciwdzialania lub leczenia niedokrwistosci
EP3157516A4 (fr) 2014-06-22 2017-12-13 Dexcel Pharma Technologies Ltd. Compositions pharmaceutiques comprenant du citrate ferrique et procédés de fabrication de celles-ci
ES2743223T3 (es) * 2014-10-27 2020-02-18 Pharmacosmos Holding As Tratamiento o prevención de la anemia en mamíferos no humanos gestantes y crías
BR112020004357A2 (pt) * 2017-09-11 2020-09-08 Pharmacosmos Holding A/S compostos de complexo de ferro para uso terapêutico
CN109646454A (zh) * 2018-12-29 2019-04-19 博瑞生物医药(苏州)股份有限公司 异麦芽糖酐铁1000的制备方法
CN110183548B (zh) * 2019-06-28 2021-05-18 瑞普(天津)生物药业有限公司 一种低分子葡聚糖铁的制备方法及其应用
JP2024529536A (ja) 2021-08-03 2024-08-06 ファーマコスモス ホールディング エー/エス コンパニオンアニマルの鉄欠乏症の治療における皮下使用のための鉄錯体化合物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK117730A (fr)
USRE24642E (en) 1959-04-28 Therapeutic preparations of iron
US2885393A (en) 1956-02-24 1959-05-05 R K Laros Company Dextran-iron complex and process for making same
US3093545A (en) 1960-08-29 1963-06-11 Armour Pharma Therapeutic iron-dextran preparations
US3234209A (en) * 1963-09-13 1966-02-08 Chemicals Inc Process for making iron hydrogenated dextran
DE1293144B (de) * 1964-11-04 1969-04-24 Hausmann Ag Labor Verfahren zur Herstellung von Komplexverbindungen des Eisens mit Sorbit, Gluconsaeure und einem Oligosaccharid
GB1183940A (en) 1966-10-22 1970-03-11 Fisons Pharmaceuticals Ltd Ferric Hydroxide Complexes
GB1200902A (en) 1967-05-13 1970-08-05 Fisons Pharmaceuticals Ltd Iron-dextran complexes
CH507993A (de) 1967-07-13 1971-05-31 Kutnowskie Zakl Farma Verfahren zur Herstellung von Eisen(III)-komplexverbindungen mit hydriertem Dextran
DK129353B (da) 1968-04-29 1974-09-30 Fisons Pharmaceuticals Ltd Analogifremgangsmåde til fremstilling af et ferrihydroxid-dextranderivatkompleks eller en opløsning deraf.
US3697502A (en) 1969-11-03 1972-10-10 Christensen Henry M Method of making iron dextran-preparations
GB1562913A (en) * 1976-06-16 1980-03-19 Fisons Ltd Fractionating fluid mixtures of dextrans
DE3422249A1 (de) * 1984-06-15 1985-12-19 Pfeifer & Langen, 5000 Köln Wasserloesliches eisendextran und verfahren zu seiner herstellung
US5102652A (en) 1986-07-03 1992-04-07 Advanced Magnetics Inc. Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
US4827945A (en) 1986-07-03 1989-05-09 Advanced Magnetics, Incorporated Biologically degradable superparamagnetic materials for use in clinical applications
IT1263831B (it) * 1993-01-29 1996-09-04 Paolo Chiesi Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina
RU2093577C1 (ru) * 1993-11-04 1997-10-20 Государственный институт кровезаменителей и медицинских препаратов Способ получения декстрана
GB9402029D0 (en) * 1994-02-03 1994-03-30 Smithkline Beecham Plc Novel formulation
US5624668A (en) * 1995-09-29 1997-04-29 Luitpold Pharmaceuticals, Inc. Iron dextran formulations

Also Published As

Publication number Publication date
CZ20003535A3 (cs) 2001-04-11
ES2180279T3 (es) 2003-02-01
EP1066056B2 (fr) 2008-12-10
KR100612071B1 (ko) 2006-08-11
UA70939C2 (uk) 2004-11-15
SK284499B6 (sk) 2005-05-05
CZ300823B6 (cs) 2009-08-19
ATE220560T1 (de) 2002-08-15
DK1066056T3 (da) 2002-10-14
CN1147322C (zh) 2004-04-28
DK42099A (da) 1999-08-16
JP2002507582A (ja) 2002-03-12
TR200002733T2 (tr) 2000-12-21
ES2180279T5 (es) 2009-05-05
EP1066056B1 (fr) 2002-07-17
DE69902154T2 (de) 2003-03-06
ZA200004016B (en) 2001-07-25
HK1033426A1 (en) 2001-08-31
HU228483B1 (en) 2013-03-28
EA200000981A1 (ru) 2001-02-26
PL343164A1 (en) 2001-07-30
KR20010034641A (ko) 2001-04-25
CA2322633A1 (fr) 1999-09-30
AU740432B2 (en) 2001-11-01
JP4558198B2 (ja) 2010-10-06
CN1293577A (zh) 2001-05-02
PT1066056E (pt) 2002-12-31
WO1999048533A1 (fr) 1999-09-30
US6291440B1 (en) 2001-09-18
DK1066056T4 (da) 2009-04-14
NO20004151L (no) 2000-08-18
NO20004151D0 (no) 2000-08-18
EA003427B1 (ru) 2003-04-24
EP1066056A1 (fr) 2001-01-10
CA2322633C (fr) 2009-01-27
PL195582B1 (pl) 2007-10-31
HUP0101189A3 (en) 2003-12-29
BRPI9908914A (pt) 2000-11-21
DE69902154D1 (de) 2002-08-22
BRPI9908914B1 (pt) 2012-06-12
BRPI9908914B8 (pt) 2021-07-06
SI1066056T2 (sl) 2009-04-30
HUP0101189A2 (hu) 2001-08-28
AU2827399A (en) 1999-10-18
NO329591B1 (no) 2010-11-15
SK14092000A3 (sk) 2001-04-09
DE69902154T3 (de) 2009-07-09
SI1066056T1 (en) 2002-12-31
NZ505983A (en) 2002-11-26
DK172860B1 (da) 1999-08-16
AR015738A1 (es) 2001-05-16

Similar Documents

Publication Publication Date Title
ID26778A (id) SENYAWA ZAT BESI-DEKSTRAN UNTUK DIGUNAKAN SEBAGAI KOMPONEN PADA KOMPOSISI TERAPEUTIK UNTUK PENCEGAHAN ATAU PENGOBATAN KEKURANGAN ZAT BESI, ......... SECARA PARENTERAL (judul disingkat untuk bisa di update
DK1196163T3 (da) Farmaceutiske sammensætninger til behandling af insulinresistens
DK2412368T3 (da) Sammensætning til behandling af ar
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
DE60016794D1 (de) Intraspinale botulinus-toxin-enthaltende verbindungen zur schmerzbehandlung
EE200200172A (et) Ühendid isheemia ravimiseks
ATE320257T1 (de) (s,s)-reboxetine zur behandlung chronischer schmerzen
DE69927946D1 (de) Verkalkungsbeständige medizinische artikel
DE50206657D1 (de) Pharmazeutische zusammensetzung zur behandlung von multiple sklerose
FI20002836A0 (fi) Menetelmä oskillaattorin säätämiseksi
DK1259512T3 (da) Pteridinforbindelser til behandling af psoreasis
ATE410430T1 (de) 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DK1165576T3 (da) Fremgangsmåde til fremstilling af amin-platin-komplekser
NO20022087D0 (no) Fremgangsmåte for behandling av diabetes
DK1282616T3 (da) Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
NO20005179D0 (no) Medikament behandling
ATE327978T1 (de) Bleichverstärkende verbindungen, zusammensetzungen und waschverfahren
DK1443938T3 (da) Dosisenhed omfattende en prostaglantinanalog til behandling af forstoppelse
TR199903132A3 (tr) Metalosan bilesiklerinin aktive edici kompozisyonu.
NO20001905L (no) (Poly)tiaalkynforbindelser og deres derivater, preparater omfattende disse og deres anvendelse
DK1150681T3 (da) Anvendelse af en farmaceutisk sammensætning indeholdende desoxypeganin til behandling af nikotinafhængighed